TY - JOUR
T1 - Ruta colombiana del colesterol. Mesa redonda nacional sobre el colesterol en Colombia. Llamado a la acción
AU - García-Peña, Ángel A.
AU - Zárate-Correa, Luz C.
AU - Campo, Rafael L.
AU - Rodríguez-Plazas, Jaime A.
AU - Aristizábal, Dagnóvar
AU - Arango, Javier
AU - Tovar, Henry
AU - Ray, Kausik
AU - Piñeiro, Daniel J.
AU - Biga, Cathleen
AU - López-Jaramillo, Patricio
AU - Gómez, Luis A.
AU - Mendivil, Carlos O.
AU - Vargas, Juan C.
AU - Romero, Andrea
AU - Cabezas, Sandra
AU - Díaz, Diana
AU - Dávila, Carmen
N1 - Publisher Copyright:
© 2023 Sociedad Colombiana de Cardiología y Cirugía Cardiovascular. Publicado por Permanyer.
PY - 2023/11/1
Y1 - 2023/11/1
N2 - Atherosclerotic cardiovascular diseases (including myocardial infarction, stroke, and peripheral arterial disease) continue to be a leading cause of premature death, disability, and healthcare expenditures worldwide. Therefore, preventing the vascular accumulation of atherogenic cholesterol-containing lipoproteins is crucial in averting major cardiovascular events. The Colombian Cholesterol Roadmap update is the outcome of a meeting held during the 2023 National Cardiology Congress, with the support of the World Heart Federation and a panel of clinical and thematic experts, along with representatives from various institutions involved in the management of dyslipidaemias in Colombia. The present update of this Cholesterol Roadmap provides a conceptual framework to describe the findings and achievements derived from working groups focused on identi-fying barriers that hinder the appropriate treatment of hypercholesterolemia in Colombia. It also outlines proposed actions adjusted to the local context, aiming to develop national policies and approaches within our healthcare systems. Furthermore, it reaffirms the commitment to intersectoral collaboration to achieve the cardiovascular health goals set for the year 2030.
AB - Atherosclerotic cardiovascular diseases (including myocardial infarction, stroke, and peripheral arterial disease) continue to be a leading cause of premature death, disability, and healthcare expenditures worldwide. Therefore, preventing the vascular accumulation of atherogenic cholesterol-containing lipoproteins is crucial in averting major cardiovascular events. The Colombian Cholesterol Roadmap update is the outcome of a meeting held during the 2023 National Cardiology Congress, with the support of the World Heart Federation and a panel of clinical and thematic experts, along with representatives from various institutions involved in the management of dyslipidaemias in Colombia. The present update of this Cholesterol Roadmap provides a conceptual framework to describe the findings and achievements derived from working groups focused on identi-fying barriers that hinder the appropriate treatment of hypercholesterolemia in Colombia. It also outlines proposed actions adjusted to the local context, aiming to develop national policies and approaches within our healthcare systems. Furthermore, it reaffirms the commitment to intersectoral collaboration to achieve the cardiovascular health goals set for the year 2030.
KW - Atherosclerotic cardiovascular diseases
KW - Dyslipidemia
KW - Health goals
KW - Hypercholesterolemia
KW - World Heart Federation
UR - http://www.scopus.com/inward/record.url?scp=85184458826&partnerID=8YFLogxK
U2 - 10.24875/RCCAR.M23000222
DO - 10.24875/RCCAR.M23000222
M3 - Artículo Científico
AN - SCOPUS:85184458826
SN - 0120-5633
VL - 30
SP - 316
EP - 321
JO - Revista Colombiana de Cardiologia
JF - Revista Colombiana de Cardiologia
IS - 6
ER -